Veradigm Inc. · OTC:MDRX
Veradigm — Allscripts Healthcare Solutions — Investor Presentation (March 2005)
21 slides from Veradigm's investor presentation, Mar 4, 2005
Slide 1: Allscripts: Inform. Connect. Transform.
ALLSCRIPTS ™ Inform. Connect. Transform.
Slide 2: Safe Harbor
Safe Harbor This presentation may contain forward-looking statements about Allscripts Healthcare Solutions that involve risks and uncertainties. These statements are developed by combining currently available information with Allscripts’ beliefs and assumptions. Forward-looking statements do not gua
Slide 3: What We Do & Who We Are
What We Do & Who We Are . . . We Provide Clinical Software, Connectivity & Information Solutions To Physicians 340 Employees Public (Nasdaq: MDRX) Financial Strength - $ 128+ Million in Cash Reserves - $ 100+ Million in 2004 Revenue - Diversified/Multiple Revenue Streams - The Leader in High Growth
Slide 4: Our Vision
Our Vision To Become an Indispensable Part of the Way Physicians Practice Medicine Why? Physicians Control 80% of a $1.6 Trillion Annual Spend
Slide 5: Our Solutions
Our Solutions Clinical Solutions Group TouchWorks™ TouchChart™ TouchScript™ Impact.MD® Physicians Interactive Group Physicians Interactive™ Patients Interactive™ iHealth Medication Services Group Allscripts Direct
Slide 6: Clinical Solutions: EHR Market Opportunity
Clinical Solutions: EHR Market Opportunity $5 Billion Market The Market Has “Tipped” < 25% Penetration of Mid to Large Size Groups 50% of Groups Purchasing in Next 18 Months* Average deal size was approximately $500,000 in 2004 Pipeline continues to grow. We also expect average deal size to grow and
Slide 7: Allscripts EHR – Competitive Advantages
Clinical Solutions: Allscripts EHR – Competitive Advantages Physician-Centric Approach IDX Alliance: Preferred Access to 70% of Large Groups Modular Approach Drives Rapid Adoption and ROI Independent, Documented Return-On-Investment Strong Reference Sites Partners Play A Key Role In Our Solution and
Slide 8: Allscripts EHR - Results
Clinical Solutions: Allscripts EHR - Results Sales Growth In Excess of 52% Client Satisfaction: 96% Would Recommend TouchWorks Ranked #1 in KLAS, the “Consumer Reports’ of Healthcare, for Ambulatory EHR Ranked #1 at TEPR Competition Microsoft HUG Awards CUMC Saves $1,000,000 in First Year of TouchWo
Slide 9: Allscripts EHR - Results
Clinical Solutions: Allscripts EHR - Results $2.7 MM $4.0 MM $1.5 MM $1.8 MM $2.4 MM $1.0 MM $2.0 MM $1.6 MM $1.3 MM $1.0 MM $1.0 MM Over 300 Deals Worth $53 Million in 2004
Slide 10: Allscripts EHR – Results
Clinical Solutions: Allscripts EHR – Results $2.7 MM $1.5 MM $1.8 MM $2.4 MM $4.0 MM $1.0 MM $2.0 MM $1.6 MM $1.3 MM $1.0 MM $1.0 MM Over 300 Deals Worth $53 Million in 2004
Slide 11: e-Prescribing Market Opportunity
Clinical Solutions: e-Prescribing Market Opportunity 3 Billion Prescriptions/Year Written on Paper in the US Less than 16 million prescriptions written electronically today. AHS processing approximately 50% Significant Backing from Payors Federal government Managed care Impact Proven and Understood
Slide 12: TouchScript eRx - Overview
Clinical Solutions: TouchScript™ eRx - Overview Most widely used e-Rx solution #1 Volume of Rx’s to RxHub .NET version, targeted at Independent Physician Market, recently launched with Microsoft, HP, Cisco, Capgemini Selected for Wellpoint and ConnectiCare Physician Automation Programs Expect signif
Slide 13: Physicians Interactive: Opportunity
Physicians Interactive: Opportunity The Opportunity Pharma Industry Marketing Spend = $15 Billion/Year Current Market for Online Product Education ~$250mm The Pharma Challenge Goal = Educate/Influence ~ 200,000 HVP’s Challenge = HVP’s Crunched For Time 43% of Pharma Detail Calls End at Receptionist
Slide 14: Physicians Interactive - Results
Physicians Interactive: - Results Pioneer/Leading Provider of e-Detailing and Other Online Solutions Blue Chip Client Base 39 Pharmaceutical, Biotech & Medical Device Companies 8 of Top 10 Pharmaceutical Companies More Programs Delivered 400 Programs for 100 Brands 59 International Programs in 8 Cou
Slide 15: Medication Services: Results
Medication Services: Results Legacy Business Continued Increases In Gross Margin Strength in Occupational Health Centers Strength in Employers On-Site Delivery
Slide 16: Financial Overview: AHS Revenue Growth Expected to Continue
Financial Overview: AHS Revenue Growth Expected to Continue $120 $100 $80 $60 $40 $20 $0 2001 2002 2003 2004 2005 E Growth Segments Medication Distribution Segment
Slide 17: Financial Overview: Translating into Positive EPS Growth
Financial Overview: Translating into Positive EPS Growth $0.30 -$0.40 $0.22 - $0.24 2002 2003 2004 2005 E
Slide 18: Financial Overview: Backlog as of December 31, 2004
Financial Overview: Backlog as of December 31, 2004 (in millions) $67.1 Million $70 $60 $50 $40 $30 $20 $10 $0 $10.6 $10.4 $35.5 TW Maintainance/ Support PI TW/TS Subscriptions TW/AIC License/Implementation Fees
Slide 19: Financial Overview: Financial Position as of December 31, 2004
Financial Overview: Financial Position as of December 31, 2004 (in millions) Cash & Marketable Securities $128.2 Accounts Receivable, Net 21.4 Other Assets 44.6 Total Assets $194.2 Accounts Payable & Accrued Liabilities $18.2 Deferred Revenue 14.6 Convertible Debt 82.5 Other Liabilities 0.2 Total Li
Slide 20: Summary
Summary Physician-Centric Competitive Advantage In Key Markets Leadership Position in All Businesses Strong Sales Momentum in Growing Markets Strong Financial Position People Bottom Line Well Positioned for Growth and Sustained Profitability
Slide 21: Allscripts Healthcare Solutions
Allscripts Healthcare Solutions
Allscripts Healthcare Solutions — Investor Presentation (March 2005) on 6ix